Ameriprise’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-28,219
| Closed | -$1.11M | – | 4026 |
|
|
2023
Q2 | $1.11M | Sell |
28,219
-1,214,980
| -98% | -$42.9M | ﹤0.01% | 3124 |
|
|
2023
Q1 | $30.2M | Buy |
1,243,199
+150,021
| +14% | +$3.28M | 0.01% | 1009 |
|
|
2022
Q4 | $23.4M | Buy |
1,093,178
+850,515
| +350% | +$18.2M | 0.01% | 1135 |
|
|
2022
Q3 | $4.35M | Buy |
+242,663
| New | +$3.19M | ﹤0.01% | 2321 |
|
|
2022
Q2 | – | Sell |
-1,041,082
| Closed | -$17.5M | – | 4022 |
|
|
2022
Q1 | $17.5M | Sell |
1,041,082
-51,402
| -5% | -$760K | 0.01% | 1457 |
|
|
2021
Q4 | $18.3M | Sell |
1,092,484
-7,503
| -0.7% | -$123K | 0.01% | 1491 |
|
|
2021
Q3 | $17.9M | Buy |
1,099,987
+6,686
| +0.6% | +$72.8K | 0.01% | 1352 |
|
|
2021
Q2 | $6.9M | Buy |
1,093,301
+23,445
| +2% | +$151K | ﹤0.01% | 2223 |
|
|
2021
Q1 | $6.61M | Buy |
1,069,856
+259,830
| +32% | +$1.58M | ﹤0.01% | 2209 |
|
|
2020
Q4 | $5.6M | Buy |
+810,026
| New | +$5.18M | ﹤0.01% | 2190 |
|
|
2018
Q2 | – | Sell |
-63,298
| Closed | -$173K | – | 3719 |
|
|
2018
Q1 | $173K | Buy |
+63,298
| New | +$183K | ﹤0.01% | 3505 |
|
|
2016
Q4 | – | Sell |
-51,585
| Closed | -$2.38M | – | 3966 |
|
|
2016
Q3 | $2.38M | Buy |
51,585
+21,393
| +71% | +$1.21M | ﹤0.01% | 2475 |
|
|
2016
Q2 | $1.54M | Sell |
30,192
-651
| -2% | -$32.3K | ﹤0.01% | 2656 |
|
|
2016
Q1 | $1.3M | Buy |
30,843
+3,080
| +11% | +$157K | ﹤0.01% | 2735 |
|
|
2015
Q4 | $2.18M | Buy |
+27,763
| New | +$1.61M | ﹤0.01% | 2553 |
|
|
2015
Q2 | – | Sell |
-19,362
| Closed | -$901K | – | 4085 |
|
|
2015
Q1 | $901K | Sell |
19,362
-6,647
| -26% | -$345K | ﹤0.01% | 2992 |
|
|
2014
Q4 | $1.17M | Sell |
26,009
-5,016
| -16% | -$211K | ﹤0.01% | 2808 |
|
|
2014
Q3 | $1.21M | Buy |
31,025
+3,315
| +12% | +$130K | ﹤0.01% | 2703 |
|
|
2014
Q2 | $1.17M | Buy |
+27,710
| New | +$1.02M | ﹤0.01% | 2718 |
|
|
2013
Q4 | – | Sell |
-13,000
| Closed | -$386K | – | 5468 |
|
|
2013
Q3 | $386K | Buy |
+13,000
| New | +$369K | ﹤0.01% | 2956 |
|
Ameriprise's ISEE Position: Q3 2023 in Review
Ameriprise sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 28,219 shares — an estimated $1.11M sold.
Ameriprise first reported a position in ISEE in Q3 2013 and held it in 20 quarters. The position peaked at $30.2M in Q1 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.
- Ameriprise reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Ameriprise sold 28,219 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $1.11M.
- Ameriprise first reported a position in IVERIC bio, Inc. Common Stock in Q3 2013 and held it in 20 quarters.
- Ameriprise's IVERIC bio, Inc. Common Stock position peaked at $30.2M in Q1 2023.
- 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.
Based on Ameriprise's 13F filing for Q3 2023, filed 14 Nov 2023.